Learn more

STEP PHARMA S A S

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    69,473
  • Filing trend
    ⇧ 1200.0%
About

STEP PHARMA S A S has a total of 24 patent applications. It increased the IP activity by 1200.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LUNDBECK LA JOLLA RESEARCH CENTER INC, BRUNCKO MILAN and ACESION PHARMA APS.

Patent filings per year

Chart showing STEP PHARMA S A Ss patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Organic fine chemistry

Top inventors

# Name Total Patents
#1 Jones Geraint 20
#2 George Pascal 20
#3 Duffy Lorna 20
#4 Novak Andrew 20
#5 Birch Louise 20
#6 Wrigglesworth Joseph 18
#7 Quddus Abdul 18
#8 Ahmed Saleh 18
#9 Cousin David 18
#10 Blackham Emma 18

Latest patents

Publication Filing date Title
WO2021053403A1 Sulfonamide inhibitors as ctps1 inhibitors
WO2021053402A2 Sulfonamide derivatives as ctps1 inhibitors
WO2020245665A1 N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases
WO2020245664A1 N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2h-pyran-4-carboxamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases
WO2020083975A1 Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors
WO2019180244A1 Aminopyrimidine derivatives as ctps1 inhibitors
KR20200135463A Aminopyrimidine derivatives as CTPS1 inhibitors
TW201940169A Compounds
WO2019106146A1 Compounds
US2021002269A1 Compounds
EP3578551A1 Sulfonamide derivatives
EP3543232A1 Aminopyrimidine derivatives as ctps1 inhibitors
EP3492454A1 Compounds